The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer
Clinical trial NCT03154983 · UNKNOWN
Trial details
- NCT number
- NCT03154983
- Sponsor
- Zhou Fuxiang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-20
- Primary completion
- 2020-12-31
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.